Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 193.94% is 83% above its 5-year average of 105.83%, near the high end of its 5-year range (50.00%–215.47%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.13% below its 12-month average of 194.19%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 193.94%.
DEBT TO ASSETS RATIO
193.94%
DEBT TO ASSETS RATIO AVG TTM
194.19%
DEBT TO ASSETS RATIO AVG 3Y
131.91%
DEBT TO ASSETS RATIO AVG 5Y
105.83%
DEBT TO ASSETS RATIO AVG 10Y
46.34%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-0.13%
CURRENT VS 3Y AVG
+47.02%
CURRENT VS 5Y AVG
+83.26%
CURRENT VS 10Y AVG
+318.49%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 592 covered companies
CURRENT VS SECTOR MEDIAN
+193837.13%
vs the sector median at left
Karyopharm Therapeutics Inc.
Market Cap
$14.58M
Debt to Assets Ratio
193.94%
TTM Avg
194.19%
3Y Avg
131.91%
5Y Avg
105.83%
Market Cap
$15.04M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.88M
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.30M
Debt to Assets Ratio
0.29%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.41M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.75M
Debt to Assets Ratio
0.69%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.06M
Debt to Assets Ratio
0.04%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Karyopharm Therapeutics Inc. (KPTI) | $14.58M | 193.94% | 194.19% | 131.91% | 105.83% |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.04M | 0.00% | N/A | N/A | N/A |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.88M | 0.05% | N/A | N/A | N/A |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.30M | 0.29% | N/A | N/A | N/A |
| IN8bio, Inc. (INAB)vs › | $13.67M | 0.10% | N/A | N/A | N/A |
| Vyome Holdings, Inc. (HIND)vs › | $13.41M | 0.00% | N/A | N/A | N/A |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.75M | 0.69% | N/A | N/A | N/A |
| BioCardia, Inc. (BCDA)vs › | $15.78M | 0.06% | N/A | N/A | N/A |
| Cellectar Biosciences, Inc. (CLRB)vs › | $13.06M | 0.04% | N/A | N/A | N/A |
| Bionano Genomics, Inc. (BNGO)vs › | $16.64M | 0.14% | N/A | N/A | N/A |
Debt/Assets
193.9%
Debt/Equity
N/A
Current Ratio
0.79
Interest Coverage
-2.0x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 193.94% |
| 2026-03-31 | 175.68% |
| 2025-12-31 | 215.47% |
| 2025-09-30 | 204.11% |
| 2025-06-30 | 181.75% |
| 2025-03-31 | 146.19% |
| 2024-12-31 | 118.31% |
| 2024-09-30 | 102.52% |
| 2024-06-30 | 91.43% |
| 2024-03-31 | 86.29% |
| 2023-12-31 | 73.62% |
| 2023-09-30 | 65.77% |
| 2023-06-30 | 59.79% |
| 2023-03-31 | 54.82% |
| 2022-12-31 | 50.00% |
| 2022-09-30 | 77.64% |
| 2022-06-30 | 70.14% |
| 2022-03-31 | 61.30% |
| 2021-12-31 | 59.15% |
| 2021-09-30 | 71.19% |
| 2021-06-30 | 63.22% |
| 2021-03-31 | 66.00% |
| 2020-12-31 | 41.89% |
| 2020-09-30 | 38.34% |
| 2020-06-30 | 33.64% |
| 2020-03-31 | 30.33% |
| 2019-12-31 | 42.28% |
| 2019-09-30 | 41.37% |
| 2019-06-30 | 51.13% |
| 2019-03-31 | 41.85% |
| 2018-12-31 | 30.09% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2012-12-31 | 0.00% |
